Your strategy is incomplete until it can be valued

Strategy without a capital markets lens

For listed companies, strategy does not exist in isolation. It is continuously evaluated, financed, and constrained by the markets and investors that fund it. Capital markets are not just an audience to be managed, they are the owners underwriting the strategy itself. Capital markets considerations are therefore not a communications exercise to be completed after the real work of strategy is done. They must be part of that work. When the capital markets lens is absent at the point decisions are made, misalignment is the predictable result of how markets operate.

Capital markets are not hostile to long-term thinking. These misalignments arise because investors are forced to be explicit where management often remains broad. Investors translate strategic choices into expectations of future cash flows, their timing, and the risks that might prevent them materializing. Where management leaves those questions unanswered, markets answer them instead – typically conservatively. What appears internally as strategic flexibility tends to register externally as uncertainty. And uncertainty, in capital markets, is not neutral: it comes with a price.

A weak valuation is therefore not always evidence of a weak strategy. Often it is evidence that the strategy has not yet been constructed or communicated in a way that markets can fully underwrite. McKinsey has made the point plainly: a company whose equity story lacks clarity signals to investors that it lacks focus, and those investors will simply look elsewhere – regardless of the underlying fundamentals.¹ The implication is uncomfortable but clear: capital markets are not the audience for strategy – they should be part of its architecture.

A strategy that can be valued

A common framing distinguishes between business strategy and equity story, assigning the latter to investor relations as a downstream activity. This distinction is misleading. There is only one strategy – and it is only complete once it can be understood, modelled, and valued by those funding it.

This requires more than a set of strategic priorities or a market narrative. It requires a coherent articulation of how an opportunity converts into revenue, how revenue scales into margins, how margins generate free cash flow, and how that cash is then allocated. The valuation curriculum has not changed on this point: intrinsic value is the present value of expected future cash flows.² Investors are not persuaded by intentions alone. They need to be able to understand and model those intentions, price the cash flows they will produce and believe in the ability of the company to deliver on them. A strategy that cannot be translated into that chain remains incomplete from a capital markets perspective. Over 80 percent of investors say that a company's equity story strongly influences their investment decisions, and they rely on explicit links between strategic priorities and financial statements to build their models.³ Put simply: a strategy is incomplete until it can be valued.

Two ways a strategy fails

Treating capital markets as an afterthought can lead to two distinct but closely related failure modes.

The first is economic. Without explicit valuation discipline, capital can be deployed in ways that fail to generate sufficient returns. This is not a messaging problem. It is a capital allocation issue. Markets ultimately assess whether resources are deployed in a way that maximizes value – not whether the strategy appears compelling internally. Strategic intent does not compensate for weak economics.

The second failure is perceptual, and often harder to diagnose because it can affect companies whose underlying economics are sound. Where strategy is not clearly translated into valuation logic, investors are left to fill in the gaps themselves. They tend to do so conservatively, applying what can be described as an ambiguity discount. A company may have strong growth and genuine competitive advantages yet still trade at a persistent discount if investors lack clarity on how value is created, when it will materialize, and how reliably it can be delivered. In that sense, the discount is not irrational. It reflects the limits of what the market can confidently underwrite.

These are distinct problems. One creates sub-optimal value. The other prevents it from being recognized. Empirical evidence supports this distinction. Companies that articulate a clear capital allocation and value creation logic tend to see stronger market reactions to strategic announcements – even where underlying performance is comparable. BCG's analysis of companies making strategic plan announcements found that those with clearer capital allocation stories saw measurably better market reactions.⁴

In practice, the two failure modes tend to reinforce one another. Weak capital allocation is harder to defend in investor conversations, while strong economics with weak translation are harder to fund on acceptable terms. Over time, this creates a negative feedback loop between execution and perception.

How markets react: the ambiguity discount

Markets form conviction through a combination of expected cash flows, timing, and credibility. The first two are standard elements of valuation. The third determines how much weight investors are willing to place on them. Credibility is built over time through a combination of clear promises, consistent delivery, and early corrections.

Investors will often tolerate temporary pressure on margins or free cash flow, provided they can see a credible path from investment to return. That path – the bridge between today’s constraints and tomorrow’s outcomes – requires clarity on sequencing, timing, and intermediate proof points. It allows investors to track progress and build conviction incrementally, rather than relying on distant assumptions.

Where that bridge is unclear, markets do not wait for clarity – they price its absence. Investors are forced to decide under uncertainty, and in doing so, they often default to more conservative assumptions. This typically manifests as reduced confidence in scale, timing, and durability of cash flows. The result is a valuation that falls short of intrinsic potential, often accompanied by higher volatility and weaker conviction. Empirical work supports this dynamic: higher uncertainty is associated with lower valuation multiples and higher required returns, while forward-looking disclosure can reduce volatility by narrowing the range of outcomes investors must price.⁵^, ⁶

This dynamic is inherently asymmetric. Markets tend to penalize uncertainty more quickly than they reward potential. A credible strategy may take time to earn a re-rating. An unclear one is discounted immediately.

There is also a time dimension that is frequently underestimated. Investors will “look through” short-term pressure, but only for a finite period. That underwriting window depends on the clarity of milestones, the visibility of progress, and the credibility of management’s commitments. When milestones are vague, deferred, or absent, that window closes. Valuations can reset even if the underlying strategy remains unchanged.

When misalignment becomes constraint

What begins as a valuation issue rarely remains one. Sustained misalignment between strategy and market understanding changes the composition and behavior of the investor base – and, with it, the context in which management operates.

The most visible expression of sustained misalignment is activism. BCG's analysis links persistent valuation underperformance relative to peers directly to activist pressure, noting 32 CEO departures in 2025 attributable to activist campaigns – including a meaningful proportion from S&P 500 companies.⁷ Shareholder activists are not drawn in by strategic ambition. They are drawn in by the gap between what a company could be worth and what it is currently valued at. That gap is, in many cases, created by misalignment rather than by operational failure – and by a capital allocation story that the market cannot fully underwrite.

Even without activism, the effects are tangible. Companies that do not clearly articulate their value creation logic tend to attract investors whose time horizons and expectations are poorly aligned with the strategy being pursued. As execution unfolds, that mismatch becomes visible in the form of resistance to investment, pressure on specific decisions, and more volatile reactions to interim performance. Investors who cannot follow the strategy tend to shorten their time horizon; those who do understand it are more likely to remain supportive through periods of uncertainty. McKinsey's work on investor base composition makes the practical consequence explicit – investors who deeply understand a company's strategy and long–term logic are more likely to remain supportive through periods of short–term volatility.⁸

Lastly, the ambiguity discount makes financing a company’s strategy more expensive. By lowering confidence in future cash flows, the ambiguity discount reduces the attractiveness of both debt and equity financing and constrains strategic flexibility. A company operating with a public valuation below intrinsic value is not just paying more for capital. It is working with a structurally smaller set of economically viable options. What began as a gap in communication can gradually become a constraint on strategic choices.

For the CFO, the consequences are both institutional and practical. The investor conversation ultimately sits with the CFO, who is expected to bridge the gap between what the strategy promises and what markets can see and underwrite. When the capital allocation logic is unclear, that gap becomes most visible in investor interactions – in earnings calls, in roadshow discussions, and in moments when strategically sound decisions are met with negative market reactions.

In that context, the ambiguity discount is not an abstract concept. It shapes the tenor of the dialogue, the level of challenge in investor conversations, and the degree of control management retains over the equity narrative.

The missing function

The persistence of this problem is not primarily an organizational issue. It is a functional one. In many organizations, responsibility for translating strategic choices into valuation outcomes is not clearly defined.

This translation is not just a communications exercise. It is a core element of strategy design. It requires explicitly mapping decisions into the economic value chain – how a given choice affects revenue, margins, free cash flow, and capital allocation; when those effects will become visible; and how long investors are likely to underwrite the interim before the ambiguity discount sets in. It also requires challenging the strategy before it is finalized, not defending it afterwards. Someone needs to ask, before decisions are taken, how a proposed course of action will be perceived by the owners of the company, what assumptions they will make if the answers are not provided, and whether the capital allocation implied by the strategy is one that can be credibly underwritten.

In practice, this role does not consistently sit in one place. In some organizations it is performed by the CFO; in others by strategy, investor relations, or directly by the CEO. That conversation – between Chairman, CEO, and CFO – is straightforward in principle and frequently avoided in practice. The CFO is often the person with the clearest line of sight to the valuation consequences of strategic choices, but not empowered unilaterally. The conversation about how capital markets responsibility enters decision making is not an organizational housekeeping exercise. It is a governance question that belongs on the board agenda.

In many companies, the function is partially performed by several parties without being fully owned by any of them. That absence is consequential. Bushee and Miller's research on investor relations practices is instructive: firms that invest seriously in the strategy-to-investor translation attract broader institutional ownership and achieve higher valuations – and doing it well requires substantial CEO and CFO involvement, not a function working downstream after the decisions are made.⁹ Many IR functions remain under-resourced relative to the mandate they are nominally given, and some surveys show that companies still lack understanding of what their investors assume – in one survey of FTSE 350 companies, only 12 percent of issuers could identify their investors' target price.¹⁰

The solution: integrate capital marketings thinking

Closing the gap between strategy and valuation requires action in two directions: internally, in how strategy is developed and maintained; and externally, in how it is understood and underwritten by the market. Strategy is only complete when it works in both dimensions.

Internally, the most effective approach is to integrate capital markets thinking into strategy from the outset before key decisions are locked in. This means evaluating strategic choices not only for their operational merit, but for their ability to translate into credible, underwritable value creation. In practice, however, most companies are not starting from a blank sheet. Strategies are already in motion. In those cases, the task is not to start again, but to revisit the strategy through a capital markets lens – making explicit how value creation is expected to materialize and refining elements where the economic logic is not yet sufficiently robust.

In practice, internal integration means building explicit decision gates into the strategy development calendar. Before a strategic initiative is approved, three questions should have been asked and answered: what assumptions does this initiative require investors to accept; over what time horizon; and what observable proof points will allow conviction to build before that horizon is reached? In most organizations, no one is formally responsible for asking these questions at the right moment. That is the gap. Closing it does not require a new function. It requires one clearly assigned owner – typically the CFO – with explicit authority to apply that filter before decisions are finalized, not after. As execution unfolds and expectations evolve, the connection between strategy and valuation must be continuously tested and recalibrated.

Externally, integration alone is not sufficient. Only strategy that is understood by the market can be valued fairly. The market needs to be able to follow the progression from investment to return, with clarity on timing, sequencing, and the proof points that allow conviction to build over time. Credibility is what sustains that conviction. It is not a matter of articulation, but of consistency – built through clear commitments, visible delivery, and early correction when assumptions prove wrong. Where understanding is incomplete, or credibility is not established, the ambiguity discount persists, regardless of the underlying strength of the strategy.

Strategy and degrees of freedom

Misalignment reduces the range of viable strategic options. That is the core consequence. It raises the cost of financing, attracts investors whose expectations conflict with the strategy being pursued, invites external intervention, and leaves management operating under tighter constraints than the underlying business would otherwise require.

Alignment, by contrast, expands strategic degrees of freedom. A company that has built credibility with its owners – through clear commitments, visible progress, and early correction – has more room to make bold decisions, to absorb temporary adversity, and to execute on its intended terms. That credibility is not inherited. It is constructed and earned, over time, through the discipline of integrating capital markets thinking into strategy.

Capital markets are the earliest and most precise expression of the constraints that ultimately shape what a company can do. Ignore that signal, and the constraints tighten. Integrate it, and management gains something strategic plans rarely make explicit, but every CEO understands intuitively: control over the company's own direction.

Strategy is not what management decides. It is what the company is able to execute in the presence of its stakeholders. That makes the capital markets lens not an afterthought to strategy, but one of its foundational inputs – and the ambiguity discount not an unfortunate market reaction, but the measurable cost of leaving it out.

For more information on how FGS Global's Equity Advisory practice supports strategy and capital markets alignment, please contact us.